S-OA-H Oral Abstracts - Session H - Pediatric Disorders & Late Effects/Quality of Life

Track: BMT Tandem "Scientific" Meeting
Friday, February 13, 2015: 10:30 AM-12:00 PM
Seaport Ballroom DE (Manchester Grand Hyatt)
Chairs:
Bipin N. Savani, MD and Paul Szabolcs, MD

Disclosures:
B. N. Savani, Nothing To Disclose

P. Szabolcs, Nothing To Disclose

106
Vitamin D Deficiency and Survival after Hematopoietic Stem Cell Transplantation
Gregory Wallace, DO, Cincinnati Children's Hospital Medical Center; Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center; Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center; Ashley Teusink, PharmD, MBA, BCPS, Cincinnati Children's Hospital Medical Center; Catherine Holtzapfel, NP, Cincinnati Children's Hospital Medical Center; Adam Lane, PhD, Cincinnati Children's Hospital Medical Center; Stella M. Davies, MBBS, PhD, MRCP, Cincinnati Children's Hospital Medical Center

107
Impact of Post-Induction Curie Scores in High-Risk Neuroblastoma
Gregory Yanik, MD, University of Michigan; Arlene Naranjo, PhD, Childrens Oncology Group; Marguerite T. Parisi, MD, Seattle Childrens Hospital; Barry L. Shulkin, MD, St. Jude Research Childrens Research Center; Helen Nadel, MD, British Columbia Childrens Hospital; Michael J Gelfand, MD, Cincinnati Childrens Hosptial Medical Center; Ruth Ladenstein, MD, St. Anna Children's Hospital; Ariane Boubaker, MD, Centre Hospitalier Universitaire Vaudois; Ulrike Poetschger, PhD, St. Anna Children's Cancer Research Institute; Dominique Valteau-Couanet, MD, Institut Gustave-Roussy; Susan G Kreissman, MD, Duke University; Julie R Park, MD, Seattle Children's Hospital; Katherine K Matthay, MD, UCSF Medical Center

57
Prospective Assessment of Familial Financial Hardship after Hematopoietic Cell Transplantation
Gregory A. Abel, MD, MPH, Dana-Farber Cancer Institute; Randy Albelda, PhD, University of Massachusetts Boston; Diana Y. Salas Coronado, MPA, Dana-Farber Cancer Institute; Lyden Marcellot, Dana-Farber Cancer Institute; Theresa Hahn, PhD, Roswell Park Cancer Institute; Nandita Khera, MD, Mayo Clinic; Reginald D. Tucker-Seeley, ScD, Dana-Farber Cancer Institute; Kira Bona, MD, MPH, Dana-Farber Cancer Institute; Oreofe O. Odejide, MD, Dana-Farber Cancer Institute; Robert J. Soiffer, MD, Dana-Farber Cancer Institute

58
Older Survivors of Allogeneic Hematopoietic Cell Transplantation (HCT) with Chronic Graft Vs. Host Disease (cGvHD) Demonstrate Higher Risk of Frailty As Compared with Autologous HCT Recipients: A Report from the Bone Marrow Transplant Survivor Study-2
Mukta Arora, MD, MS, University of Minnesota Medical Center; Canlan Sun, PhD, City of Hope; Kirsten Ness, PT PhD, St. Jude Children's Research Hospital; Jennifer Berano Teh, MD, City of Hope; Amy Schad, MPH, City of Hope; Cara Hanby, CCRP, City of Hope; Liton Francisco, City of Hope; Karen Hou, City of Hope; Jessica Wu, City of Hope; Linus Kuo, City of Hope; Saro H. Armenian, DO, MPH, City of Hope; Daniel J. Weisdorf, MD, University of Minnesota Medical Center; Stephen J. Forman, City of Hope Medical Center; Smita Bhatia, MD, MPH, City of Hope National Medical Center

59
Cardiac CT Imaging Is a Feasible Screening Strategy for Coronary Artery Disease (CAD) in Long Term Allogeneic Stem Cell Transplant (Allo-SCT) Survivors
Natasha A Jain, MD, National Heart, Lung, and Blood Institute, NIH; Marcus Y Chen, MD, National Heart, Lung, and Blood Institute, NIH; Sujata Shanbhag, MD, National Heart, Lung, and Blood Institute, NIH; Prathima Anandi, MD, National Heart, Lung, and Blood Institute, NIH; Kit Lu, MD, National Heart, Lung, and Blood Institute, NIH; Priyanka A Pophali, MD, National Heart, Lung, and Blood Institute, NIH; Neil Dunavin, MD, National Heart, Lung, and Blood Institute, NIH; Sawa Ito, MD, National Heart, Lung, and Blood Institute, NIH; Eleftheria Koklanaris, RN, National Heart, Lung, and Blood Institute, NIH; Christopher S. Hourigan, MD, PhD, National Heart, Lung, and Blood Institute, NIH; A. John Barrett, MD, National Heart, Lung, and Blood Institute, NIH; Minoo Battiwalla, MD, MS, National Heart, Lung, and Blood Institute, NIH

60
Long-Term Follow-up after Hematopoietic Stem Cell Transplantation for Patients with Fanconi Anemia: A Single Center Experience on 157 Patients Surviving 2 or More Years after Transplant
Carmem Bonfim, MD, Federal University of Paraná; Lisandro Ribeiro, MD, Federal University of Paraná; Samantha Nichele, MD, Federal University of Parana; Marco Bitencourt, MD, Federal University of Parana; Mary Eapen, MBBS, MS, CIBMTR/Medical College of Wisconsin; Mary E. D. Flowers, MD, Fred Hutchinson Cancer Research Center; Gisele Loth, MD, Federal University of Paraná; Cilmara Kuwahara, MD, Hospital Infantil Pequeno Príncipe; Ana Luiza Melo Rodrigues, MD, Federal University of Parana; Vaneuza Araujo Moreira Funke, MD, MS, Federal University of Parana; Ricardo Pasquini, MD, Federal University of Parana